文献速递妇科

Fitbit项目改善子宫内膜癌幸存者健康的II期试验

Phase II trial evaluating efficacy of a Fitbit program for improving the health of endometrial cancer survivors.
PubMed 文献 · Gynecol Oncol · 2021-02-05

这项II期试验纳入46例子宫内膜腺癌(IA-IIIA期)治疗后≥3个月的幸存者,随机接受电话或电子方式沟通的Fitbit干预。基线中位每日步数5641步,6个月时平均步数增加22%,但9个月时回落至基线;仅电话干预组在多个时间点活动水平增加但未维持。低基线幸福感者身体和社交幸福感轻度改善。

要点

  • Fitbit项目使6个月步数增加22%,但9个月回落至基线。
  • 仅电话干预组在多个时间点活动增加,但未维持至9个月。
  • 基线活动水平是活动量最强预测因素,BMI无变化。

核心结论

  • 子宫内膜癌幸存者活动水平低,Fitbit项目联合电话干预仅轻度改善且效果未持续至研究结束。
  • 项目对高基线步行频率且低基线步数的电话干预患者影响最大,其他人可能需要更强干预。

研究设计与样本

  • II期随机试验,纳入46例可分析患者,诊断为IA-IIIA期子宫内膜腺癌且治疗后≥3个月。
  • 参与者接受Fitbit Alta,随机分入电话或电子(邮件/短信)沟通组,每两周沟通一次持续两个月,第4和第5个月各一次,每周评估平均每日步数持续九个月。

主要发现

  • 基线中位每日平均步数为5641步,6个月时平均步数增加22%,9个月时降至基线。
  • 基线活动水平(每日步数和每周步行次数)是活动水平的最强预测因素。
  • 仅电话干预组在多个时间点活动水平增加,但9个月时未维持;BMI无变化。
  • 低基线幸福感者身体和社交幸福感轻度改善(p=0.009和0.014),与干预组无关;情绪幸福感与步数相关(p=0.005)。

临床怎么用

  • Fitbit项目联合电话沟通可短期提升子宫内膜癌幸存者步数,但需更强化干预以维持长期生活方式改变。
  • 基线活动水平低且步行频率高者可能从电话干预中获益更多。

局限性

  • 可分析样本仅46例,结果可能受限。
  • 干预效果未持续至9个月研究结束。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Despite the favorable prognosis of early stage endometrial cancer, mortality from cardiovascular disease is high. We aimed to evaluate the efficacy of a Fitbit program to improve physical activity in endometrial cancer survivors. METHODS: Eligible patients were diagnosed with stage IA-IIIA endometrial adenocarcinoma, ≥3 months out from treatment. Participants received a Fitbit Alta and were randomized to receive communication via telephone or electronic methods (email/text). Communication was every two weeks for two months, then once during months four and five. Average daily steps were assessed weekly for nine months. RESULTS: The 46 analyzable patients demonstrated a baseline of 5641 median daily average steps. Average steps increased by 22% at 6 months but decreased to baseline by nine months. Baseline activity level (daily steps and walks per week) was the greatest predictor of activity level. Only the telephone intervention participants demonstrated increased activity level at several timepoints, although not maintained by nine months. BMI was unchanged. There was mild improvement in physical and social well-being in those with low baseline well-being (p = 0.009 and 0.014, respectively), regardless of intervention group. Emotional well-being correlated with step count (p = 0.005). CONCLUSIONS: Activity level was low and mildly improved on the Fitbit program with the telephone intervention, but effects did not persist by study completion. The program had the greatest impact on a select group of telephone intervention patients with high baseline walking frequency and low baseline step count. Others may require more intense intervention to promote more robust/persistent lifestyle changes.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Rahimy E, Usoz M, von Eyben R, et al. Phase II trial evaluating efficacy of a Fitbit program for improving the health of endometrial cancer survivors. Gynecol Oncol. 2021. PMID: 33551199. doi:10.1016/j.ygyno.2021.01.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。